This product represents the third prescription solution commercialized by Jaguar's family company, Napo Pharmaceuticals. Oral mucositis, often referred to as "chemo mouth," is a significant ...
The stock of small-cap biotech Jaguar Health Inc. rose 3% on Wednesday, after the company launched its gelclair treatment for oral mucositis, a common side effect suffered by head and neck cancer ...